Osęka M, Saładziak K, Jamrozy-Witkowska A, Dziedziak J, Cudnoch-Jędrzejewska A, Święch A. The potential usage of D2 dopaminergic agonists in the treatment of VEGF-related eye diseases. Ophthatherapy [Internet]. 2020Mar.31 [cited 2024Apr.27];7(1):36-9. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/973